QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
NYSE:MMS

Maximus - MMS Stock Forecast, Price & News

$74.25
-0.60 (-0.80%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$73.31
$75.62
50-Day Range
$71.31
$84.33
52-Week Range
$54.46
$85.25
Volume
332,086 shs
Average Volume
384,849 shs
Market Capitalization
$4.51 billion
P/E Ratio
24.03
Dividend Yield
1.51%
Price Target
$100.00

Maximus MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
34.7% Upside
$100.00 Price Target
Short Interest
Healthy
2.16% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.42mentions of Maximus in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$790,167 Sold Last Quarter
Proj. Earnings Growth
13.25%
From $4.15 to $4.70 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.04 out of 5 stars

Business Services Sector

17th out of 322 stocks

Business Services, Not Elsewhere Classified Industry

8th out of 90 stocks


MMS stock logo

About Maximus (NYSE:MMS) Stock

MAXIMUS, Inc. engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S. state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions and includes appeals and assessment services, system and application development, IT modernization, and maintenance services. The Outside the U.S segment provides BPS for international governments and commercial clients. The company was founded by David V. Mastran in 1975 and is headquartered in McLean, VA.

Receive MMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

MMS Stock News Headlines

The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
Maximus (MMS) is a Great Momentum Stock: Should You Buy?
Maximus (NYSE:MMS) Is Paying Out A Dividend Of $0.28
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
Maximus Reports Fiscal Year 2023 First Quarter Results
Raymond James Reaffirms Their Buy Rating on Maximus (MMS)
Maximus (MMS) to Post Q1 Earnings: What's in the Offing?
Maximus, Inc. (NYSE:MMS) Q4 2022 Earnings Call Transcript
Why Is Maximus (MMS) Up 1.4% Since Last Earnings Report?
Why Maximus Shares Are Trading Sharply Higher
Maximus (MMS) Beats Q4 Earnings and Revenue Estimates
See More Headlines
Receive MMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

MMS Company Calendar

Last Earnings
2/08/2023
Ex-Dividend for 2/28 Dividend
2/14/2023
Dividend Payable
2/28/2023
Today
3/23/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Data Processing & Outsourced Services
CUSIP
57793310
Employees
39,500
Year Founded
1975

Price Target and Rating

Average Stock Price Forecast
$100.00
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$100.00
Forecasted Upside/Downside
+34.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$203.83 million
Pretax Margin
5.48%

Debt

Sales & Book Value

Annual Sales
$4.63 billion
Cash Flow
$6.41 per share
Book Value
$25.23 per share

Miscellaneous

Free Float
59,983,000
Market Cap
$4.51 billion
Optionable
Optionable
Beta
0.69

Social Links


Key Executives

  • Bruce L. CaswellBruce L. Caswell
    President, Chief Executive Officer & Director
  • David Mutryn
    Chief Financial Officer & Treasurer
  • Michael S. Weiner
    Chief Medical Officer
  • John W. Lambeth
    Chief Information Officer
  • Elisabeth Schmidt
    Senior VP-Technology & Consulting Services













MMS Stock - Frequently Asked Questions

Should I buy or sell Maximus stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MMS shares.
View MMS analyst ratings
or view top-rated stocks.

What is Maximus' stock price forecast for 2023?

1 brokers have issued 1 year price objectives for Maximus' stock. Their MMS share price forecasts range from $100.00 to $100.00. On average, they expect the company's share price to reach $100.00 in the next year. This suggests a possible upside of 34.7% from the stock's current price.
View analysts price targets for MMS
or view top-rated stocks among Wall Street analysts.

How have MMS shares performed in 2023?

Maximus' stock was trading at $73.33 at the beginning of the year. Since then, MMS shares have increased by 1.3% and is now trading at $74.25.
View the best growth stocks for 2023 here
.

Are investors shorting Maximus?

Maximus saw a drop in short interest during the month of February. As of February 28th, there was short interest totaling 1,300,000 shares, a drop of 23.5% from the February 13th total of 1,700,000 shares. Based on an average trading volume of 400,800 shares, the days-to-cover ratio is presently 3.2 days. Currently, 2.2% of the shares of the stock are sold short.
View Maximus' Short Interest
.

When is Maximus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our MMS earnings forecast
.

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) posted its quarterly earnings results on Wednesday, February, 8th. The health services provider reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.15. The health services provider had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.15 billion. Maximus had a net margin of 4.03% and a trailing twelve-month return on equity of 16.64%. The business's revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.12 EPS.

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus announced a quarterly dividend on Tuesday, January 10th. Stockholders of record on Wednesday, February 15th will be given a dividend of $0.28 per share on Tuesday, February 28th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date is Tuesday, February 14th.
Read our dividend analysis for MMS
.

Is Maximus a good dividend stock?

Maximus (NYSE:MMS) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.46%. The dividend payout ratio is 36.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 23.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

What guidance has Maximus issued on next quarter's earnings?

Maximus updated its FY 2023 earnings guidance on Friday, February, 10th. The company provided earnings per share (EPS) guidance of $4.00-$4.30 for the period, compared to the consensus EPS estimate of $3.82. The company issued revenue guidance of $4.85 billion-$5.00 billion, compared to the consensus revenue estimate of $4.77 billion.

What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are Maximus' major shareholders?

Maximus' stock is owned by many different retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (11.09%), Victory Capital Management Inc. (11.09%), Fuller & Thaler Asset Management Inc. (4.76%), Alliancebernstein L.P. (4.62%), Mackenzie Financial Corp (4.51%) and Geode Capital Management LLC (2.00%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau, Teresa Weipert, Thomas D Romeo and Thomas D Romeo.
View institutional ownership trends
.

How do I buy shares of Maximus?

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $74.25.

How much money does Maximus make?

Maximus (NYSE:MMS) has a market capitalization of $4.51 billion and generates $4.63 billion in revenue each year. The health services provider earns $203.83 million in net income (profit) each year or $3.09 on an earnings per share basis.

How many employees does Maximus have?

The company employs 39,500 workers across the globe.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The official website for the company is www.maximus.com. The health services provider can be reached via phone at (703) 251-8500, via email at investorrelations@maximus.com, or via fax at 703-251-8240.

This page (NYSE:MMS) was last updated on 3/23/2023 by MarketBeat.com Staff